Published in PLoS Genet on April 02, 2015
Lysophospholipids in coronary artery and chronic ischemic heart disease. Curr Opin Lipidol (2015) 0.81
Genetic and environmental risk factors for atherosclerosis regulate transcription of phosphatase and actin regulating gene PHACTR1. Atherosclerosis (2016) 0.80
Neural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration. Sci Rep (2016) 0.76
Regulation of Lysophosphatidic Acid Metabolism and Signaling by Lipoproteins. Arterioscler Thromb Vasc Biol (2016) 0.75
Heterarchy of transcription factors driving basal and luminal cell phenotypes in human urothelium. Cell Death Differ (2017) 0.75
Association between PPAP2B gene polymorphisms and coronary heart disease susceptibility in Chinese Han males and females. Oncotarget (2017) 0.75
Functional transcription factor target discovery via compendia of binding and expression profiles. Sci Rep (2016) 0.75
PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population. Oncotarget (2016) 0.75
Role of lipid phosphate phosphatase 3 (LPP3) in human aortic endothelial cell function. Cardiovasc Res (2016) 0.75
Transcriptome Profiling in Systems Vascular Medicine. Front Pharmacol (2017) 0.75
Maintenance of macrophage transcriptional programs and intestinal homeostasis by epigenetic reader SP140. Sci Immunol (2017) 0.75
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest (1955) 31.08
Genomewide association analysis of coronary artery disease. N Engl J Med (2007) 24.38
lumi: a pipeline for processing Illumina microarray. Bioinformatics (2008) 17.19
GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol (2010) 16.72
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med (1989) 15.67
Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A (2010) 15.13
Systematic localization of common disease-associated variation in regulatory DNA. Science (2012) 14.47
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature (2010) 12.07
Atherosclerosis. the road ahead. Cell (2001) 11.88
HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res (2011) 11.03
Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res (2010) 9.55
Macrophages in the pathogenesis of atherosclerosis. Cell (2011) 7.78
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Super-enhancers in the control of cell identity and disease. Cell (2013) 7.50
Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet (2011) 6.98
A map of open chromatin in human pancreatic islets. Nat Genet (2010) 6.75
An atlas of active enhancers across human cell types and tissues. Nature (2014) 6.57
The immune system in atherosclerosis. Nat Immunol (2011) 6.51
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature (2011) 6.25
A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet (2011) 5.23
F-Seq: a feature density estimator for high-throughput sequence tags. Bioinformatics (2008) 4.77
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res (2011) 4.43
Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A (1995) 4.31
CEAS: cis-regulatory element annotation system. Bioinformatics (2009) 4.26
Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol (2011) 4.13
Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol (2013) 3.85
Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat Genet (2012) 3.67
Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med (1990) 3.29
Transcriptional enhancers: from properties to genome-wide predictions. Nat Rev Genet (2014) 3.16
Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol (2012) 3.01
Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell (2011) 2.97
Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J (2011) 2.66
Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat Genet (2014) 2.38
Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A (1999) 2.33
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation (2011) 1.96
PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. PLoS Genet (2011) 1.93
Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA. Nat Protoc (2012) 1.84
Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell (2013) 1.79
Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet (2011) 1.72
Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis (1995) 1.70
A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet (2011) 1.63
Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 1.61
diffReps: detecting differential chromatin modification sites from ChIP-seq data with biological replicates. PLoS One (2013) 1.58
The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Development (2003) 1.57
Molecular biology of atherosclerosis. Physiol Rev (2013) 1.49
LPA receptor signaling: pharmacology, physiology, and pathophysiology. J Lipid Res (2014) 1.47
Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet (2013) 1.47
Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol Rev (2012) 1.38
Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood (2012) 1.36
Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase. J Biol Chem (1997) 1.34
Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23. Eur Heart J (2010) 1.25
Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation. PLoS Genet (2011) 1.24
Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ Res (2014) 1.24
Lipid phosphate phosphatase 3 enables efficient thymic egress. J Exp Med (2011) 1.23
Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice. Mol Endocrinol (2012) 1.21
Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage. Cell Signal (2012) 1.19
Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells. Mol Biol Cell (1999) 1.16
Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.14
Sphingosine 1-phosphate signalling. Development (2014) 1.14
Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci. Genome Res (2013) 1.10
Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J Lipid Res (2013) 1.09
Adipophilin is a sensitive marker for lipid loading in human blood monocytes. Biochim Biophys Acta (2001) 1.09
CCAAT/enhancer-binding protein β (C/EBPβ) expression regulates dietary-induced inflammation in macrophages and adipose tissue in mice. J Biol Chem (2012) 1.07
Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet (2014) 1.06
A dynamic H3K27ac signature identifies VEGFA-stimulated endothelial enhancers and requires EP300 activity. Genome Res (2013) 1.05
Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet (2014) 1.05
Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia. Arterioscler Thromb Vasc Biol (2012) 1.04
The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation. J Immunol (2014) 1.04
Lysophosphatidic acid in atherosclerotic diseases. Br J Pharmacol (2012) 1.01
Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol (2010) 1.01
NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site. J Biol Chem (2011) 1.00
Lipid phosphate phosphatases form homo- and hetero-oligomers: catalytic competency, subcellular distribution and function. Biochem J (2008) 0.99
Lipid phosphate phosphatase (LPP3) and vascular development. Biochim Biophys Acta (2012) 0.99
Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures. Mol Cell Biol (2010) 0.96
Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells. BMC Genomics (2014) 0.94
Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.94
Generation of a conditional Ppap2b/Lpp3 null allele. Genesis (2007) 0.93
PeaKDEck: a kernel density estimator-based peak calling program for DNaseI-seq data. Bioinformatics (2014) 0.89
Roles nrf2 plays in myeloid cells and related disorders. Oxid Med Cell Longev (2013) 0.89
Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. Curr Diab Rep (2013) 0.88
Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development. Glia (2011) 0.88
Mapping open chromatin with formaldehyde-assisted isolation of regulatory elements. Methods Mol Biol (2011) 0.81
Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides. Bioanalysis (2012) 0.80
Nuclear receptor mediated mechanisms of macrophage cholesterol metabolism. Mol Cell Endocrinol (2012) 0.79
The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease. PLoS Genet (2015) 1.08
Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. PLoS Genet (2014) 0.89
Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation. PLoS Genet (2015) 0.82
The South Asian genome. PLoS One (2014) 0.81
Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells. Front Immunol (2020) 0.75